El 1017 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from El 1017. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In El 1017 Today - Breaking & Trending Today

Relmada Up 6% On Results From Phase 3 REL-1017 Study

Published: September 20, 2023

Relmada Therapeutics, Inc. (RLMD) saw a 6% increase in share value on Monday. This was due to the announcement of efficacy and safety results from their Phase 3 study (Study REL-1017-310) of REL-1017 in patients with Major Depressive Disorder (MDD).

Source: rttnews.com

Related Topics:

Relmada Therapeutics IncRelmada TherapeuticsMajor Depressive DisorderPhase 3Relmada TherapeuticsEl 1017